KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX)

CUSIP: 492515101

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COMMON STOCK
Total 13F shares
79,316,434
Share change
-101,219
Total reported value
$563,154,880
Put/Call ratio
114%
Price per share
$7.10
Number of holders
131
Value change
-$628,742
Number of buys
61
Number of sells
43

Quarterly Holders Quick Answers

What is CUSIP 492515101?
CUSIP 492515101 identifies KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q3 2017

As of 30 Sep 2017, KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 79,316,434 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, BlackRock Inc., ABRAMS CAPITAL MANAGEMENT, L.P., Consonance Capital Management LP, STATE STREET CORP, FMR LLC, NORGES BANK, CLEARBRIDGE, LLC, and RICE HALL JAMES & ASSOCIATES, LLC. This page lists 131 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.